FindTrial
Sign In

Clinical higher investigation of Rheumatoid Arthritis patients receiving Ayurvedic therapy.

Clinical Metabolomics investigation of Rheumatoid Arthritis patients receiving Ayurvedic whole system intervention

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/07/044348
Enrollment
30
Registered
2022-07-26
Start date
Unknown
Completion date
Unknown
Last updated
2022-08-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M057- Rheumatoid arthritis with rheumatoid factor without organ or systems involvement Health Condition 2: M057- Rheumatoid arthritis with rheumatoid factor without organ or systems involvement

Interventions

None listed

Sponsors

State Ayurvedic College and Hospital Lucknow
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients not in remission state as per DAS-28 ESR criteria.

Exclusion criteria

Exclusion criteria: Having co-morbid conditions like Osteoarthritis, Gout etc.

Design outcomes

Primary

MeasureTime frame
Clinical metabolomic assessment and clinical outcome among the people registered under the study following the Ayurvedic whole system intervention will be done through DAS-28 ESR scoring. Final assessment will be done with the help of ACR20, ACR50 and ACR70 criteria. This clinical outcome assessment will be supplemented by quantitative evaluation of inflammatory markers like ESR/CRP.Timepoint: 12 weeks—

Secondary

MeasureTime frame
Quality of life improvement.Timepoint: 12 weeks—

Countries

India

Contacts

Public ContactAnkita Verma

State Ayurvedic College and Hospital, Lucknow

rastogisanjeev@rediffmail.com9415022955

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026